Literature DB >> 8611693

JAK2 is associated with the c-kit proto-oncogene product and is phosphorylated in response to stem cell factor.

S R Weiler1, S Mou, C S DeBerry, J R Keller, F W Ruscetti, D K Ferris, D L Longo, D Linnekin.   

Abstract

Stem cell factor (SCF) is a hematopoietic growth factor that interacts with the receptor tyrosine kinase, c-kit. We have found that SCF-stimulates rapid and transient tyrosine phosphorylation of JAK2 in human and murine cell lines, as well as in normal human progenitor cells. JAK2 and c-kit were associated in unstimulated cells with further recruitment of JAK2 to the c-kit receptor complex after SCF stimulation. Treatment of cells with JAK2 antisense oligonucleotides resulted in a 46% decrease in SCF-induced proliferation. These data demonstrate that SCF induces tyrosine phosphorylation of JAK2 and suggest that JAK2 is a component of the SCF signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611693

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.

Authors:  Jeffrey W Tyner; Denise K Walters; Stephanie G Willis; Mary Luttropp; Jason Oost; Marc Loriaux; Heidi Erickson; Amie S Corbin; Thomas O'Hare; Michael C Heinrich; Michael W Deininger; Brian J Druker
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

2.  SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.

Authors:  M Kozlowski; L Larose; F Lee; D M Le; R Rottapel; K A Siminovitch
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

3.  Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML.

Authors:  James Marvin; Suchitra Swaminathan; Geoffrey Kraker; Amy Chadburn; James Jacobberger; Charles Goolsby
Journal:  Blood       Date:  2011-01-13       Impact factor: 22.113

4.  Differential biological activity of disease-associated JAK2 mutants.

Authors:  Haiying Zou; Dongqing Yan; Golam Mohi
Journal:  FEBS Lett       Date:  2011-03-04       Impact factor: 4.124

5.  Lyn is activated during late G1 of stem-cell-factor-induced cell cycle progression in haemopoietic cells.

Authors:  S Mou; D Linnekin
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

6.  Critical role of Jak2 in the maintenance and function of adult hematopoietic stem cells.

Authors:  Hajime Akada; Saeko Akada; Robert E Hutchison; Kazuhito Sakamoto; Kay-Uwe Wagner; Golam Mohi
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

Review 7.  A clinical and biological overview of gastrointestinal stromal tumors.

Authors:  Myrna Candelaria; Jaime de la Garza; Alfonso Duenas-Gonzalez
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

8.  Kras is Required for Adult Hematopoiesis.

Authors:  Alisa Damnernsawad; Guangyao Kong; Zhi Wen; Yangang Liu; Adhithi Rajagopalan; Xiaona You; Jinyong Wang; Yun Zhou; Erik A Ranheim; Hongbo R Luo; Qiang Chang; Jing Zhang
Journal:  Stem Cells       Date:  2016-03-28       Impact factor: 6.277

9.  Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.

Authors:  Florian Grebien; Marc A Kerenyi; Boris Kovacic; Thomas Kolbe; Verena Becker; Helmut Dolznig; Klaus Pfeffer; Ursula Klingmüller; Mathias Müller; Hartmut Beug; Ernst W Müllner; Richard Moriggl
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

10.  Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression.

Authors:  Jerzy Ostrowski; Marcin Polkowski; Agnieszka Paziewska; Magdalena Skrzypczak; Krzysztof Goryca; Tymon Rubel; Katarzyna Kokoszyñska; Piotr Rutkowski; Zbigniew I Nowecki; Anna Jerzak Vel Dobosz; Dorota Jarosz; Wlodzimierz Ruka; Lucjan S Wyrwicz
Journal:  BMC Cancer       Date:  2009-11-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.